Pacer Wealthshield ETF (PWS) Stock Price, Quote & News

Company Profile

The index utilizes a systematic risk management strategy that directs the index's exposure to U.S. equity securities, U.S. Treasury securities, or a mix of each. The Advisor attempts to invest all, or substantially all, of its assets in the component securities that make up (i) the component securities of the index or (ii) ETFs that seek to track the performance of some or all of the component securities of the index in the same approximate weight as such component securities.

Phone: (610) 644-8100

AlphaTuna Apr. 22 at 11:19 PM

Lowest Volume Rated ETFs Per 4/22/2026’s Close: 1 – $USCA 2 – $LRND 3 – $AMUN 4 – $WDTE 5 – $JPY 6 – $CPAG 7 – $HYSA 8 – $TUG 9 – $PWS 10 – $NUGO https://optimizedvalue.xyz/daily-voltech-stock-etf-volume-technical-ratings-4-22-2026/

0 · Reply

BillionerOfKing Jan. 28 at 9:32 PM

$PWS Current Stock Price: $33.33

0 · Reply

PenkeInvesting May. 6 at 11:35 AM

I found you an Oversold RSI (Relative Strength Index) on the daily chart of Pacer WealthShield. Is that bullish or bearish? $PWS #RsiOversold #BATS

0 · Reply

PenkeInvesting Nov. 26 at 11:59 PM

I found you an Overbought RSI (Relative Strength Index) on the daily chart of Pacer WealthShield. Is that bullish or bearish? $PWS #RsiOverbought #BATS

0 · Reply

ConSynance Therapeutics Announces First Patient Dosed in Phase 2a Clinical Trial of CSTI-500 for Prader-Willi Syndrome

Jun 15, 2026, 4:10 PM EDT - 3 days ago

Soleno Therapeutics Presents New VYKAT® XR (diazoxide choline) Data at ENDO 2026 Demonstrating Meaningful and Durable Improvements in Hyperphagia and Behavioral Symptoms in Prader-Willi Syndrome Following Randomized Withdrawal Period

NBIX

Jun 13, 2026, 8:01 AM EDT - 5 days ago

Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026

RYTM

Jun 12, 2026, 4:01 PM EDT - 6 days ago

Rhythm Pharmaceuticals to Announce Interim Six-Month Phase 2 Results Evaluating Setmelanotide in Patients with Prader-Willi Syndrome

RYTM

Jun 9, 2020, 2:00 AM EDT - 6 years ago

Saniona Receives Positive Feedback from FDA on Regulatory Path for Tesomet in Prader-Willi Syndrome (PWS)

AlphaTuna Apr. 22 at 11:19 PM

0 · Reply

BillionerOfKing Jan. 28 at 9:32 PM

$PWS Current Stock Price: $33.33

0 · Reply

PenkeInvesting May. 6 at 11:35 AM

I found you an Oversold RSI (Relative Strength Index) on the daily chart of Pacer WealthShield. Is that bullish or bearish? $PWS #RsiOversold #BATS

0 · Reply

PenkeInvesting Nov. 26 at 11:59 PM

I found you an Overbought RSI (Relative Strength Index) on the daily chart of Pacer WealthShield. Is that bullish or bearish? $PWS #RsiOverbought #BATS

0 · Reply

Market Cap	N/A
Revenue (ttm)	N/A
Net Income (ttm)	N/A
EPS (ttm)	N/A
PE Ratio	N/A
Forward PE	N/A
Profit Margin	N/A
Debt to Equity Ratio	N/A

Volume	2,400
Avg Vol	N/A
Day's Range	N/A - N/A
Shares Out	N/A
Stochastic %K	N/A
Beta	N/A
Analysts	N/A
Price Target	N/A